FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to a method for the prediction of developing occupational hyperkeratosis. Substance of the method consists in recovering DNA from peripheral venous blood lymphocytes, genotyping TP53 gene rs1625895 polymorphism by polymerase chain reaction with restriction enzyme digest analysis. Finding G/A genotype and A allele ensured predicting a risk of developing occupational hyperkeratosis.
EFFECT: using the invention enables predicting developing occupational hyperkeratosis after the body has been exposed to occupational hazards.
2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF DEVELOPING OCCUPATIONAL MALIGNANT SKIN GROWTHS IN FIBREGLASS PRODUCTION WORKERS | 2011 |
|
RU2454668C1 |
METHOD FOR PREDICTION OF MALIGNANT TRANSFORMATION OF EROSIVE-ULCEROUS LICHEN ACUMINATUS OF ORAL MUCOSA | 2015 |
|
RU2580222C1 |
METHOD FOR PREDICTION OF STERILITY IN WOMEN WORKING IN PETROCHEMICAL PRODUCTION | 2008 |
|
RU2386133C1 |
METHOD FOR PREDICTION OF RESPIRATORY FAILURE IN PATIENTS WITH BRONCHIAL ASTHMA | 2017 |
|
RU2639122C1 |
METHOD FOR PREDICTION OF FORMATION OF CHRONIC LYMPHOTIC LEUKEMIA AND ONSET DEVELOPMENT OF COMBINED COMPLICATIONS | 2011 |
|
RU2458349C1 |
METHOD OF RISK PREDICTION OF BRONCHIAL ASTHMA | 2006 |
|
RU2324937C1 |
METHOD FOR PREDICTION OF RISK OF PARANOID SCHIZOPHRENIA | 2012 |
|
RU2506595C2 |
METHOD FOR PREDICTING THE DEVELOPMENT OF FLAT FEET IN YOUNG PEOPLE | 2022 |
|
RU2784354C1 |
METHOD FOR PREDICTION OF CLINICAL FORM OF CHRONIC LYMPHOLEUKAEMIA | 2012 |
|
RU2490642C1 |
METHOD FOR PREDICTING THE RISK OF A SKIN PATHOLOGY IN THE FORM OF MELANOSIS OR DYSCHROMIA ASSOCIATED WITH EXCESSIVE ARSENIC CONTAMINATION IN A HUMAN | 2019 |
|
RU2714325C1 |
Authors
Dates
2015-07-27—Published
2014-02-05—Filed